Veradermics

Veradermics is a biopharmaceutical company focused on clinical-stage aesthetics and dermatology, developing first-class treatments for common skin conditions. The company's lead candidate, VDPHL01, is a non-hormonal oral treatment currently being evaluated for the treatment of AGA/PHL in both men and women. Other pipeline programs address common skin conditions, including common warts and molluscum contagiosum.